The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
GlaxoSmithKline (GSK) has turned to the US for its new general counsel, hiring Sidley Austin life sciences partner Dan Troy following a seven-month search.
Former GSK general counsel Rupert Bondy joined energy company BP in May after announcing his departure in January. Troy will start at GSK on 2 September. GSK refused to confirm who is acting as interim general counsel.
Troy has been at Sidley for the past four years, serving as a partner in the life sciences practice as well as in the appellate litigation group. In addition to private practice he ;has ;experience ;of in-house legal work, having been chief counsel for the US Food and Drug Administration, where he was a primary liaison to the White House and the US Department of Health and Human Services.
Troy will report to GSK CEO Andrew Witty, who said: ;“Dan’s ;wealth ;of experience in the regulatory legislative area will be of enormous benefit to us, and ultimately to patients.”